var data={"name":"Endocrine tumors","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Adrenal tumors","type":"SUBSECTION","items":[{"name":"Clinical features, diagnosis, and management of von Hippel-Lindau disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-diagnosis-and-management-of-von-hippel-lindau-disease"},{"name":"Diagnosis of primary aldosteronism","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-of-primary-aldosteronism"},{"name":"Epidemiology and clinical manifestations of Cushing's syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-and-clinical-manifestations-of-cushings-syndrome"},{"name":"Establishing the cause of Cushing's syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=establishing-the-cause-of-cushings-syndrome"},{"name":"Establishing the diagnosis of Cushing's syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=establishing-the-diagnosis-of-cushings-syndrome"},{"name":"Medical therapy of hypercortisolism (Cushing's syndrome)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=medical-therapy-of-hypercortisolism-cushings-syndrome"},{"name":"Overview of the treatment of Cushing's syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-treatment-of-cushings-syndrome"},{"name":"Pathophysiology and clinical features of primary aldosteronism","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathophysiology-and-clinical-features-of-primary-aldosteronism"},{"name":"Primary therapy of Cushing's disease: Transsphenoidal surgery and pituitary irradiation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-therapy-of-cushings-disease-transsphenoidal-surgery-and-pituitary-irradiation"},{"name":"The adrenal incidentaloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-adrenal-incidentaloma"},{"name":"Treatment of adrenocortical carcinoma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-adrenocortical-carcinoma"},{"name":"Treatment of primary aldosteronism","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-primary-aldosteronism"}]},{"name":"Carcinoid tumors","type":"SUBSECTION","items":[{"name":"Carcinoid heart disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=carcinoid-heart-disease"},{"name":"Clinical characteristics of well-differentiated neuroendocrine (carcinoid) tumors arising in the tubular digestive tract, lung, and genitourinary tract","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-characteristics-of-well-differentiated-neuroendocrine-carcinoid-tumors-arising-in-the-tubular-digestive-tract-lung-and-genitourinary-tract"},{"name":"Clinical features of the carcinoid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-of-the-carcinoid-syndrome"},{"name":"Diagnosis of the carcinoid syndrome and tumor localization","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-of-the-carcinoid-syndrome-and-tumor-localization"},{"name":"Staging, treatment, and posttreatment surveillance of nonmetastatic, well-differentiated gastrointestinal tract neuroendocrine (carcinoid) tumors","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=staging-treatment-and-posttreatment-surveillance-of-nonmetastatic-well-differentiated-gastrointestinal-tract-neuroendocrine-carcinoid-tumors"},{"name":"Treatment of the carcinoid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-the-carcinoid-syndrome"}]},{"name":"Metastatic disease","type":"SUBSECTION","items":[{"name":"Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth and symptoms of hormone hypersecretion","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=metastatic-gastroenteropancreatic-neuroendocrine-tumors-local-options-to-control-tumor-growth-and-symptoms-of-hormone-hypersecretion"},{"name":"Metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=metastatic-well-differentiated-gastroenteropancreatic-neuroendocrine-tumors-presentation-prognosis-imaging-and-biochemical-monitoring"},{"name":"Metastatic well-differentiated gastrointestinal neuroendocrine (carcinoid) tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=metastatic-well-differentiated-gastrointestinal-neuroendocrine-carcinoid-tumors-systemic-therapy-options-to-control-tumor-growth-and-symptoms-of-hormone-hypersecretion"},{"name":"Metastatic well-differentiated pancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=metastatic-well-differentiated-pancreatic-neuroendocrine-tumors-systemic-therapy-options-to-control-tumor-growth-and-symptoms-of-hormone-hypersecretion"}]},{"name":"Multiple endocrine neoplasia","type":"SUBSECTION","items":[{"name":"Approach to therapy in multiple endocrine neoplasia type 2","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-therapy-in-multiple-endocrine-neoplasia-type-2"},{"name":"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-multiple-endocrine-neoplasia-type-2"},{"name":"Multiple endocrine neoplasia type 1: Clinical manifestations and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=multiple-endocrine-neoplasia-type-1-clinical-manifestations-and-diagnosis"},{"name":"Multiple endocrine neoplasia type 1: Definition and genetics","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=multiple-endocrine-neoplasia-type-1-definition-and-genetics"},{"name":"Multiple endocrine neoplasia type 1: Treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=multiple-endocrine-neoplasia-type-1-treatment"}]},{"name":"Pancreatic endocrine tumors","type":"SUBSECTION","items":[{"name":"Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine neoplasms","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=classification-epidemiology-clinical-presentation-localization-and-staging-of-pancreatic-neuroendocrine-neoplasms"},{"name":"Clinical features, diagnosis, and management of von Hippel-Lindau disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-diagnosis-and-management-of-von-hippel-lindau-disease"},{"name":"Diagnostic dilemmas in hypoglycemia: Illustrative cases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnostic-dilemmas-in-hypoglycemia-illustrative-cases"},{"name":"Glucagonoma and the glucagonoma syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=glucagonoma-and-the-glucagonoma-syndrome"},{"name":"Insulinoma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=insulinoma"},{"name":"Management and prognosis of the Zollinger-Ellison syndrome (gastrinoma)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-and-prognosis-of-the-zollinger-ellison-syndrome-gastrinoma"},{"name":"Somatostatinoma: Clinical manifestations, diagnosis, and management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=somatostatinoma-clinical-manifestations-diagnosis-and-management"},{"name":"VIPoma: Clinical manifestations, diagnosis, and management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=vipoma-clinical-manifestations-diagnosis-and-management"},{"name":"Zollinger-Ellison syndrome (gastrinoma): Clinical manifestations and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=zollinger-ellison-syndrome-gastrinoma-clinical-manifestations-and-diagnosis"}]},{"name":"Parathyroid tumors","type":"SUBSECTION","items":[{"name":"Parathyroid carcinoma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=parathyroid-carcinoma"},{"name":"Parathyroid cysts","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=parathyroid-cysts"},{"name":"Pathogenesis and etiology of primary hyperparathyroidism","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-and-etiology-of-primary-hyperparathyroidism"},{"name":"Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=preoperative-localization-for-parathyroid-surgery-in-patients-with-primary-hyperparathyroidism"},{"name":"Primary hyperparathyroidism: Clinical manifestations","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-hyperparathyroidism-clinical-manifestations"},{"name":"Primary hyperparathyroidism: Diagnosis, differential diagnosis, and evaluation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-hyperparathyroidism-diagnosis-differential-diagnosis-and-evaluation"},{"name":"Primary hyperparathyroidism: Management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-hyperparathyroidism-management"}]},{"name":"Pituitary tumors","type":"SUBSECTION","items":[{"name":"Causes and clinical manifestations of acromegaly","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=causes-and-clinical-manifestations-of-acromegaly"},{"name":"Causes, presentation, and evaluation of sellar masses","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=causes-presentation-and-evaluation-of-sellar-masses"},{"name":"Clinical manifestations and diagnosis of gonadotroph and other clinically nonfunctioning pituitary adenomas","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-gonadotroph-and-other-clinically-nonfunctioning-pituitary-adenomas"},{"name":"Diagnosis of acromegaly","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-of-acromegaly"},{"name":"Diagnostic testing for hypopituitarism","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnostic-testing-for-hypopituitarism"},{"name":"Management of hyperprolactinemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-hyperprolactinemia"},{"name":"Management of lactotroph adenoma (prolactinoma) during pregnancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-lactotroph-adenoma-prolactinoma-during-pregnancy"},{"name":"TSH-secreting pituitary adenomas","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=tsh-secreting-pituitary-adenomas"},{"name":"Treatment of acromegaly","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-acromegaly"},{"name":"Treatment of gonadotroph and other clinically nonfunctioning adenomas","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-gonadotroph-and-other-clinically-nonfunctioning-adenomas"}]},{"name":"Thyroid tumors","type":"SUBSECTION","items":[{"name":"Anaplastic thyroid cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=anaplastic-thyroid-cancer"},{"name":"Differentiated thyroid cancer refractory to standard treatment: Chemotherapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=differentiated-thyroid-cancer-refractory-to-standard-treatment-chemotherapy"},{"name":"Differentiated thyroid cancer: Clinicopathologic staging","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=differentiated-thyroid-cancer-clinicopathologic-staging"},{"name":"Differentiated thyroid cancer: External beam radiotherapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=differentiated-thyroid-cancer-external-beam-radiotherapy"},{"name":"Differentiated thyroid cancer: Overview of management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=differentiated-thyroid-cancer-overview-of-management"},{"name":"Differentiated thyroid cancer: Radioiodine treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=differentiated-thyroid-cancer-radioiodine-treatment"},{"name":"Differentiated thyroid cancer: Role of serum thyroglobulin","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=differentiated-thyroid-cancer-role-of-serum-thyroglobulin"},{"name":"Differentiated thyroid cancer: Surgical treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=differentiated-thyroid-cancer-surgical-treatment"},{"name":"Exogenous hyperthyroidism","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=exogenous-hyperthyroidism"},{"name":"Medullary thyroid cancer: Chemotherapy and immunotherapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=medullary-thyroid-cancer-chemotherapy-and-immunotherapy"},{"name":"Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=medullary-thyroid-cancer-clinical-manifestations-diagnosis-and-staging"},{"name":"Medullary thyroid cancer: Treatment and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=medullary-thyroid-cancer-treatment-and-prognosis"},{"name":"Papillary thyroid cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=papillary-thyroid-cancer"},{"name":"Radiation-induced thyroid cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=radiation-induced-thyroid-cancer"},{"name":"Struma ovarii","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=struma-ovarii"}]}]}